Liu Wei, Zhu Xiaoqing, Wang Qian, Wang Linlin
Department of Prosthetics, Stomatology Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, P.R. China.
Exp Ther Med. 2013 May;5(5):1289-1292. doi: 10.3892/etm.2013.978. Epub 2013 Feb 27.
Diabetic osteoporosis is a metabolic bone disease responsible for global health problems. Hyperglycemia induces osteopenia, increases bone fragility and unbalances the coupling of osteoblasts and osteoclasts. The mechanism is, however, unknown. For the purpose of this study, we hypothesized that hyperglycemia destroys endoplasmic reticulum (ER) homeostasis, activates C/EBP-homologous protein (CHOP) and induces osteoblast apoptosis under diabetic conditions. Diabetic rats were created by injecting streptozotocin (STZ) 65 mg/kg intraperitoneally and their osteoblasts were cultured under high-glucose medium . The bone mineral density (BMD) and pathological changes of the rats' femurs were observed. The expression of CHOP in osteoblasts was assayed using immunohistochemistry and western blot analysis. Six weeks after diabetic model establishment, a significant decrease was found in the BMD of the diabetic rat femurs, and the numbers of osteoblasts under cortical bone were also reduced. The expression of the ER stress regulator CHOP in osteoblasts of diabetic rats or high-glucose medium was also elevated (P<0.01). The present results demonstrated that hyperglycemia elevated the expression of CHOP and finally led to osteoporosis. This suggested that elevating the expression of CHOP may play a role in diabetic osteoporosis.
糖尿病性骨质疏松症是一种导致全球健康问题的代谢性骨病。高血糖会诱发骨质减少,增加骨骼脆性,并破坏成骨细胞与破骨细胞之间的耦合平衡。然而,其机制尚不清楚。在本研究中,我们假设高血糖会破坏内质网(ER)稳态,激活C/EBP同源蛋白(CHOP),并在糖尿病条件下诱导成骨细胞凋亡。通过腹腔注射65mg/kg链脲佐菌素(STZ)制备糖尿病大鼠,并将其成骨细胞在高糖培养基中培养。观察大鼠股骨的骨密度(BMD)和病理变化。采用免疫组织化学和蛋白质印迹分析检测成骨细胞中CHOP的表达。糖尿病模型建立六周后,发现糖尿病大鼠股骨的骨密度显著降低,皮质骨下的成骨细胞数量也减少。糖尿病大鼠或高糖培养基中成骨细胞中内质网应激调节因子CHOP的表达也升高(P<0.01)。目前的结果表明,高血糖会升高CHOP的表达,最终导致骨质疏松症。这表明升高CHOP的表达可能在糖尿病性骨质疏松症中起作用。